Advertisements

Mylan-Natco faces uphill battle in gaining market share from Teva#39;s MS drug

Mylan-Natco faces uphill battle in gaining market share from Teva#39;s MS drug.....»»

Category: topSource: moneycontrolNov 9th, 2018

Biocon-Mylan faces competition in US for trastuzumab from Teva-Celltrion duo

Biocon-Mylan faces competition in US for trastuzumab from Teva-Celltrion duo.....»»

Category: topSource: moneycontrolDec 21st, 2018

Sun Pharma settles Modafinil antitrust litigation with certain US plaintiffs

Sun Pharma settles Modafinil antitrust litigation with certain US plaintiffs.....»»

Category: topSource: moneycontrolNov 26th, 2018

Patanjali Ayurved faces uphill task without Ruchi Soya - Livemint

Patanjali Ayurved faces uphill task without Ruchi Soya - Livemint.....»»

Category: topSource: googlenewsAug 26th, 2018

Natco Pharma spurts 20% on USFDA nod for multiple sclerosis drug

Natco Pharma spurts 20% on USFDA nod for multiple sclerosis drug.....»»

Category: marketsSource: thehindubusinesslineOct 4th, 2017

Accumulate rating on Natco, target price of Rs 940: Nirmal Bang

Accumulate rating on Natco, target price of Rs 940: Nirmal Bang.....»»

Category: topSource: moneycontrolOct 4th, 2017

Indivior launches generic version of opioid drug after losing court battle

Indivior launches generic version of opioid drug after losing court battle.....»»

Category: global-financeSource: reutersFeb 20th, 2019

Gulf Oil rises over 5% after Emkay Global initiates coverage with #39;buy#39; rating

Gulf Oil rises over 5% after Emkay Global initiates coverage with #39;buy#39; rating.....»»

Category: topSource: moneycontrolDec 4th, 2018

Battle for market share

Battle for market share.....»»

Category: topSource: mydigitalfcOct 22nd, 2018

HDFC Bank Q2 review: Scaling new highs in a tough environment; buy

HDFC Bank Q2 review: Scaling new highs in a tough environment; buy.....»»

Category: topSource: moneycontrolOct 22nd, 2018

MARKETS LIVE: Indices range-bound, Nifty above 10300; financial stocks gain - Business Standard

MARKETS LIVE: Indices range-bound, Nifty above 10300; financial stocks gain - Business Standard.....»»

Category: topSource: googlenewsOct 22nd, 2018

Natco#39;s partner Mylan prevails over Teva in Copaxone patent litigation

Natco#39;s partner Mylan prevails over Teva in Copaxone patent litigation.....»»

Category: topSource: moneycontrolOct 13th, 2018

Tata Motors picks up speed, CV mkt share at 3-yr high, shy of FY15 numbers - Business Standard

Tata Motors picks up speed, CV mkt share at 3-yr high, shy of FY15 numbers - Business Standard.....»»

Category: topSource: googlenewsOct 2nd, 2018

Teva to hold Indivior generic drug launch pending US ruling

Teva to hold Indivior generic drug launch pending US ruling.....»»

Category: topSource: moneycontrolSep 12th, 2018

Merck profit beats, but Keytruda sales fail to impress

Merck profit beats, but Keytruda sales fail to impress.....»»

Category: global-financeSource: reutersJul 27th, 2018

McDonald"s U.S. same-store sales miss estimates, share drop

McDonald"s U.S. same-store sales miss estimates, share drop.....»»

Category: global-financeSource: reutersJul 26th, 2018

VietJet provisionally orders 100 Boeing 737 jets

VietJet provisionally orders 100 Boeing 737 jets.....»»

Category: global-financeSource: reutersJul 18th, 2018

Apple gains in OS market, equals brand share with Samsung in US: Report

Apple gains in OS market, equals brand share with Samsung in US: Report.....»»

Category: infotechSource: sifyJul 18th, 2018

Samsung gears up to battle Chinese rivals in TV market

Samsung gears up to battle Chinese rivals in TV market.....»»

Category: topSource: the-hinduJun 14th, 2018

Havells India Q4 review – Strong performance; Outlook optimistic

Havells India Q4 review – Strong performance; Outlook optimistic.....»»

Category: topSource: moneycontrolMay 14th, 2018

Trader"s guide to India elections says it is time to buy equities

Trader"s guide to India elections says it is time to buy equities.....»»

Category: featuresSource: business-standardApr 26th, 2018